Related Experiment Video
Updated: Feb 3, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Global Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Model: A Systematic Review and
Sheng-Chu Chi1, Hsin-Ho Chang2, Tai-Chi Lin1
1Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan (R.O.C.).
Insights
The G-ROP criteria show high sensitivity for screening retinopathy of prematurity (ROP), especially for severe ROP. However, its low specificity may limit use in resource-limited settings.
Area of Science:
- Ophthalmology
- Neonatology
- Public Health
Background:
- Retinopathy of prematurity (ROP) is a leading cause of blindness in premature infants.
- The G-ROP criteria, incorporating postnatal weight gain, are validated for ROP screening.
- Optimizing ROP screening is crucial to prevent vision loss.
Purpose of the Study:
- To assess the diagnostic accuracy of the G-ROP algorithm for various ROP outcomes.
- To explore sources of heterogeneity in G-ROP performance.
- To evaluate the potential of G-ROP to reduce screening examinations.
Main Methods:
- Systematic review and meta-analysis of studies using G-ROP for ROP prediction.
- Searched PubMed, EMBASE, and Cochrane databases through September 2024.
- Assessed risk of bias (QUADAS-2) and certainty of evidence (GRADE).
Main Results:
- High sensitivity (0.99) for type 1 ROP, with low specificity (0.34).
- High sensitivity (0.98) for type 2 ROP, with low specificity (0.25).
- Moderate sensitivity (0.87) and specificity (0.45) for any-stage ROP.
Conclusions:
- The G-ROP algorithm demonstrates high sensitivity for detecting severe ROP (type 1 and treated).
- Its high sensitivity supports its role in ROP screening, potentially reducing exams.
- Low specificity may limit its utility in resource-constrained settings requiring minimized unnecessary screenings.
Topic:
The Postnatal Growth and Retinopathy of Prematurity (G-ROP) criteria, incorporating postnatal weight gain, are widely validated for retinopathy of prematurity (ROP) screening. We assessed the G-ROP algorithm's diagnostic accuracy across various outcomes and explored heterogeneity sources.
Clinical Relevance:
If G-ROP maintains sensitivity with fewer examinations, it would optimize screening for this blinding disease.
Methods:
We searched PubMed, Embase, and Cochrane databases (through September 2024) for studies using G-ROP to predict type 1, type 2, treated, or any-stage ROP. We assessed risk of bias using Quality Assessment of Diagnostic Accuracy Studies-2 and certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. The protocol was prospectively registered with International Prospective Register of Systematic Reviews (CRD42024571794).
Results:
Twenty-three studies were included. For type 1 ROP (17 cohorts; 1406 infants), sensitivity was 0.99 (95% confidence interval [CI]: 0.99-1.00; I2 = 44.5%) and specificity (9 cohorts; 2522 infants) was 0.34 (95% CI: 0.32-0.36; I2 = 96.3%). The diagnostic odds ratio (DOR) was 6.22 (95% CI: 2.34-16.53; I2 = 40.7%), and the area under the curve (AUC) was 0.87 (95% CI: 0.83-0.90). Certainty of evidence was high for sensitivity and low for specificity and DOR. For type 2 ROP, pooled sensitivity from 9 cohorts (871 infants) was 0.98 (95% CI: 0.97-0.99; I2 = 41.4%), whereas specificity from 3 cohorts (621 infants) was 0.25 (95% CI: 0.22-0.29; I2 = 92.2%). The DOR was 3.21 (95% CI: 1.24-8.28; I2 = 0%), and the AUC was 0.76 (95% CI: 0.72-0.80). Certainty was high for sensitivity, very low for specificity, and moderate for DOR. For any-stage ROP, pooled sensitivity from 16 cohorts (3674 infants) was 0.87 (95% CI: 0.86-0.88; I2 = 90.2%), whereas specificity from 13 cohorts (2846 infants) was 0.45 (95% CI: 0.43-0.47; I2 = 95.8%). The DOR was 5.88 (95% CI: 3.89-8.89; I2 = 75.3%), and the AUC was 0.78 (95% CI: 0.74-0.81). Certainty was low for sensitivity, low for specificity, and moderate for DOR.
Conclusion:
The G-ROP algorithm demonstrates consistently high sensitivity, particularly for type 1 and treated ROP, supporting its use as a screening tool for severe disease. Although the model reduces examinations compared with current standards, its low specificity may limit its usefulness in low-resource settings, where minimizing unnecessary screening is essential.
Financial Disclosure(S):
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Related Concept Videos
Global Climate Change
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Reliability and Validity
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups

